| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
10,039 |
8,328 |
$802K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,724 |
3,156 |
$429K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,647 |
2,505 |
$316K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,369 |
2,096 |
$247K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
5,947 |
5,419 |
$180K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,395 |
1,360 |
$158K |
| 90461 |
|
3,227 |
2,993 |
$91K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,587 |
1,523 |
$85K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,720 |
1,609 |
$78K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
542 |
532 |
$63K |
| 97803 |
|
3,118 |
2,899 |
$58K |
| 99188 |
|
3,241 |
2,981 |
$37K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,671 |
1,308 |
$33K |
| 90670 |
|
1,152 |
1,086 |
$31K |
| 99383 |
|
233 |
223 |
$29K |
| 99382 |
|
172 |
170 |
$22K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
169 |
146 |
$18K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
4,610 |
3,608 |
$18K |
| 90710 |
|
705 |
694 |
$16K |
| 99381 |
|
145 |
138 |
$14K |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
1,031 |
992 |
$12K |
| 99384 |
|
84 |
82 |
$12K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
767 |
747 |
$10K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
213 |
207 |
$8K |
| 92552 |
|
1,140 |
967 |
$6K |
| 83655 |
|
716 |
693 |
$6K |
| 96160 |
|
3,892 |
3,295 |
$5K |
| 99173 |
|
3,682 |
3,410 |
$4K |
| 85018 |
|
3,496 |
3,173 |
$4K |
| 96127 |
|
2,420 |
1,873 |
$4K |
| 97802 |
|
176 |
173 |
$3K |
| 92551 |
|
2,552 |
2,445 |
$2K |
| 90686 |
|
1,644 |
1,580 |
$2K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
236 |
229 |
$2K |
| 81002 |
|
1,069 |
1,020 |
$2K |
| 90680 |
|
732 |
719 |
$2K |
| 90633 |
|
1,125 |
1,088 |
$2K |
| 90651 |
|
178 |
173 |
$1K |
| 96161 |
|
990 |
830 |
$1K |
| 90671 |
|
186 |
185 |
$1K |
| G2024 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source |
59 |
57 |
$1K |
| 90677 |
|
224 |
223 |
$953.35 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
145 |
120 |
$882.31 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
57 |
38 |
$858.08 |
| 90698 |
|
268 |
244 |
$763.08 |
| 0071A |
|
15 |
15 |
$553.37 |
| 0072A |
|
13 |
13 |
$520.00 |
| 94664 |
|
61 |
42 |
$437.63 |
| 94667 |
|
150 |
73 |
$370.01 |
| 90648 |
|
1,037 |
998 |
$361.31 |
| G9919 |
Screening performed and positive and provision of recommendations |
1,582 |
1,531 |
$346.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
16 |
16 |
$336.14 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
108 |
101 |
$276.12 |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
93 |
72 |
$249.89 |
| 90734 |
|
187 |
182 |
$187.89 |
| 90696 |
|
97 |
96 |
$172.72 |
| 90620 |
|
26 |
26 |
$150.94 |
| 90723 |
|
546 |
538 |
$97.97 |
| A7015 |
Aerosol mask, used with dme nebulizer |
63 |
59 |
$95.53 |
| 90700 |
|
189 |
185 |
$58.39 |
| 90681 |
|
12 |
12 |
$24.01 |
| 36416 |
|
88 |
88 |
$5.28 |
| A7005 |
Administration set, with small volume nonfiltered pneumatic nebulizer, non-disposable |
31 |
14 |
$0.00 |
| 94060 |
|
63 |
30 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
510 |
476 |
$0.00 |
| 90656 |
|
12 |
12 |
$0.00 |
| 91307 |
|
41 |
32 |
$0.00 |
| 90744 |
|
15 |
15 |
$0.00 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
23 |
12 |
$0.00 |